Stage-stratified analysis of prognostic significance of bax-interacting factor-1 expression in resected colorectal cancer

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Ko, Yoon Ho ^a   Cho, Young Seok ^a   Won, Hye Sung ^a   An, Ho Jung ^a   Sun, Der Sheng ^a   Hong, Soon Uk ^b   Park, Jin Hee ^c   Lee, Myung Ah ^d  

^a Uijeongbu St Mary's Hospital   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BAX INTERACTING FACTOR 1; FLUOROURACIL; PROTEIN; UNCLASSIFIED DRUG; SH3GLB1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; ADULT; BIOSYNTHESIS; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885639437     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/329839     Document Type: Article

References (28)

1. Pisani P., Parkin D. M., Bray F., Ferlay J., Estimates of the worldwide mortality from 25 cancers in 1990. International Journal of Cancer 1999 83 1 18 29 (Pubitemid 29409471)
2. Sung J. J. Y., Lau J. Y. W., Goh K. L., Leung W. K., Chen M. H., Li C. J., Tandon R., Makharia G., Abdullah M., Fujita R., Hilmi I., Kim J. Y., Kim H. J., Yang S.-K., Kim W. H., Kim T. II, Byeon J.-S., Hilmi I., Sollano J., Ong E., Tan J., Ho L., Yeoh K. G., Wang C.-Y., Wu D.-C., Kongkam P., Kullavanijaya P., Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncology 2005 6 11 871 876 2-s2.0-27744507676 10.1016/S1470-2045(05) 70422-8 (Pubitemid 41614799)
3. Weitz J., Koch M., Debus J., Höhler T., Galle P. R., Büchler M. W., Colorectal cancer. Lancet 2005 365 9454 153 165 2-s2.0-11844273837 10.1016/S0140-6736(05)17706-X (Pubitemid 40091806)
4. Hector S., Prehn J. H. M., Apoptosis signaling proteins as prognostic biomarkers in colorectal cancer: a review. Biochimica et Biophysica Acta 2009 1795 2 117 129 2-s2.0-62849099895 10.1016/j.bbcan.2008.12.002
5. Cuddeback S. M., Yamaguchi H., Komatsu K., Miyashita T., Yamada M., Wu C., Singh S., Wang H.-G., Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. Journal of Biological Chemistry 2001 276 23 20559 20565 2-s2.0-0035827622 10.1074/jbc.M101527200
6. Pierrat B., Simonen M., Cueto M., Mestan J., Ferrigno P., Heim J., SH3GLB, a new endophilin-related protein family featuring an SH3 domain. Genomics 2001 71 2 222 234 2-s2.0-0035862577 10.1006/geno.2000.6378 (Pubitemid 32165089)
7. Takahashi Y., Karbowski M., Yamaguchi H., Kazi A., Wu J., Sebti S. M., Youle R. J., Wang H.-G., Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Molecular and Cellular Biology 2005 25 21 9369 9382 2-s2.0-27144544082 10.1128/MCB.25.21.9369-9382.2005 (Pubitemid 41507838)
8. Takahashi Y., Coppola D., Matsushita N., Cualing H. D., Sun M., Sato Y., Liang C., Jung J. U., Cheng J. Q., Mulé J. J., Pledger W. J., Wang H.-G., Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nature Cell Biology 2007 9 10 1142 1151 2-s2.0-34848899280 10.1038/ncb1634 (Pubitemid 47500490)
9. Takahashi Y., Hori T., Cooper T. K., Liao J., Desai N., Serfass J. M., Young M. M., Park S., Izu Y., Wang H. G., Bif-1 haploinsufficiency promotes chromosomal instability and accelerates Myc-driven lymphomagenesis via suppression of mitophagy. Blood 2013 121 9 1622 1632
10. Mizushima N., Levine B., Cuervo A. M., Klionsky D. J., Autophagy fights disease through cellular self-digestion. Nature 2008 451 7182 1069 1075 2-s2.0-39849109338 10.1038/nature06639 (Pubitemid 351317450)
11. Knuutila S., Aalto Y., Autio K., Björkqvist A.-M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M. L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.-M., Wolf M., Zhu Y., DNA copy number losses in human neoplasms. American Journal of Pathology 1999 155 3 683 694 2-s2.0-0032887168 (Pubitemid 29426813)
12. Lee J. W., Jeong E. G., Soung Y. H., Nam S. W., Lee J. Y., Yoo N. J., Lee S. H., Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 2006 38 4 312 315 2-s2.0-33747592333 10.1080/00313020600820880 (Pubitemid 44266628)
13. Coppola D., Oliveri C., Sayegh Z., Boulware D., Takahashi Y., Pow-Sang J., Djeu J. Y., Wang H.-G., Bax-interacting factor-1 expression in prostate cancer. Clinical Genitourinary Cancer 2008 6 2 117 121 2-s2.0-58149190801 10.3816/CGC.2008.n.018
14. Kim S. Y., Oh Y. L., Kim K. M., Jeong E. G., Kim M. S., Yoo N. J., Lee S. H., Decreased expression of Bax-interacting factor-1 (Bif-1) in invasive urinary bladder and gallbladder cancers. Pathology 2008 40 6 553 557 2-s2.0-50449094644 10.1080/00313020802320440
15. Coppola D., Helm J., Ghayouri M., Malafa M. P., Wang H.-G., Down-regulation of bax-interacting factor 1 in human pancreatic ductal adenocarcinoma. Pancreas 2011 40 3 433 437 2-s2.0-79954423742 10.1097/MPA.0b013e318205eb03
16. Coppola D., Khalil F., Eschrich S. A., Boulware D., Yeatman T., Wang H.-G., Down-regulation of bax-interacting factor-1 in colorectal adenocarcinoma. Cancer 2008 113 10 2665 2670 2-s2.0-55849126198 10.1002/cncr.23892
17. Fan R., Miao Y., Shan X., Qian H., Song C., Wu G., Chen Y., Zha W., Bif-1 is overexpressed in hepatocellular carcinoma and correlates with shortened patient survival. Oncology Letters 2012 3 4 851 854 2-s2.0-84856846020 10.3892/ol.2012.562
18. Kim M. S., Yoo N. J., Lee S. H., Somatic mutation of pro-cell death Bif-1 gene is rare in common human cancers. APMIS 2008 116 10 939 940 2-s2.0-58149089453 10.1111/j.1600-0463.2008.01091.x
19. Knösel T., Petersen S., Schwabe H., Schlüns K., Stein U., Schlag P., Dietel M., Petersen I., Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases. Virchows Archiv 2002 440 2 187 194 2-s2.0-0036175753 10.1007/s004280100493 (Pubitemid 34169857)
20. Camps J., Armengol G., del Rey J., Lozano J. J., Vauhkonen H., Prat E., Egozcue J., Sumoy L., Knuutila S., Miró R., Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 2006 27 3 419 428 2-s2.0-33644860129 10.1093/carcin/bgi244 (Pubitemid 43372871)
21. Jansson A., Sun X.-F., Bax expression decreases significantly from primary tumor to metastasis in colorectal cancer. Journal of Clinical Oncology 2002 20 3 811 816 2-s2.0-0036467867 10.1200/JCO.20.3.811 (Pubitemid 34111390)
22. Katkoori V. R., Suarez-Cuervo C., Shanmugam C., Jhala N. C., Callens T., Messiaen L., Posey J. III, Bumpers H. L., Meleth S., Grizzle W. E., Manne U., Bax expression is a candidate prognostic and predictive marker of colorectal cancer. Journal of Gastrointestinal Oncology 2010 1 2 76 89
23. Sturm I., Köhne C.-H., Wolff G., Petrowsky H., Hillebrand T., Hauptmann S., Lorenz M., Dörken B., Daniel P. T., Analysis of the p53/BAX pathway in colorectal cancer: low BAX is a negative prognostic factor in patients with resected liver metastases. Journal of Clinical Oncology 1999 17 5 1364 1374 2-s2.0-0344348993 (Pubitemid 29220841)
24. Ho J., Kong J.-W., Choong L.-Y., Loh M.-C., Toy W., Chong P.-K., Wong C.-H., Wong C.-Y., Shah N., Lim Y.-P., Novel breast cancer metastasis-associated proteins. Journal of Proteome Research 2009 8 2 583 594 2-s2.0-61849154412 10.1021/pr8007368
25. Marx J., Autophagy: is it cancer's friend or foe? Science 2006 312 5777 1160 1161 2-s2.0-33744988159 10.1126/science.312.5777.1160
26. Liang X. H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B., Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999 402 6762 672 676 2-s2.0-0000906170 10.1038/45257 (Pubitemid 129516338)
27. Takahashi Y., Meyerkord C. L., Hori T., Runkle K., Fox T. E., Kester M., Loughran T. P., Wang H.-G., Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi membranes during autophagy. Autophagy 2011 7 1 61 73 2-s2.0-78650816366 10.4161/auto.7.1.14015
28. Mathew R., Karantza-Wadsworth V., White E., Assessing metabolic stress and autophagy status in epithelial tumors. Methods in Enzymology 2009 453 53 81 2-s2.0-59649106359 10.1016/S0076-6879(08)04004-4